Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Follow-Up Questions
Danaher Corp (DHR)'in P/E oranı nedir?
Danaher Corp 'in P/E oranı 37.9513 'dir
Danaher Corp 'in CEO'su kimdir?
Mr. Rainer Blair 2014 'den beri şirketle birlikte olan Danaher Corp 'in President 'ıdır.
DHR hissesinin fiyat performansı nasıl?
DHR 'in mevcut fiyatı $214.31 'dir, son işlem günde 0.22% increased etti.
Danaher Corp için ana iş temaları veya sektörler nelerdir?
Danaher Corp Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
Danaher Corp 'in piyasa değerlemesi nedir?
Danaher Corp 'in mevcut piyasa değerlemesi $153.4B 'dir
Danaher Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 23 analist Danaher Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 12 güçlü al, 15 al, 3 tut, 0 sat ve 12 güçlü sat içermektedir
